These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7554542)

  • 1. Ventricular tachyarrhythmias, myocardial ischemia, and sudden cardiac death in patients with hypertensive heart disease.
    Zehender M; Faber T; Koscheck U; Meinertz T; Just H
    Clin Cardiol; 1995 Jul; 18(7):377-83. PubMed ID: 7554542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evidence for the fatal interaction of ventricular tachyarrhythmias, myocardial ischemia and sudden cardiac death.
    Zehender M; Faber T; Meinertz T; Just H
    Herz; 1995 Jun; 20(3):187-99. PubMed ID: 7635400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension, myocardial ischemia, and sudden death.
    Yamani MH; Massie BM
    Curr Opin Cardiol; 1994 Sep; 9(5):542-50. PubMed ID: 7987033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretics, arrhythmias and silent myocardial ischaemia in hypertensive patients.
    Storstein L
    Eur Heart J; 1992 Dec; 13 Suppl G():81-4. PubMed ID: 1486911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertensive heart disease, ventricular dysrhythmias, and sudden death.
    Messerli FH; Michalewicz L
    Adv Exp Med Biol; 1997; 432():263-72. PubMed ID: 9433533
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute myocardial ischemia, ventricular tachyarrhythmias and sudden cardiac death].
    Zehender M; Faber T; Just H
    Dtsch Med Wochenschr; 1994 Dec; 119(51-52):1786-91. PubMed ID: 7736934
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertensive heart disease--significance of left ventricular hypertrophy.
    Schmieder RE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular arrhythmias in left ventricular hypertrophy and heart failure.
    Bayés de Luna A; Viñolas Prat X; Guindo J
    Eur Heart J; 1993 Nov; 14 Suppl J():62-4. PubMed ID: 8281965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor].
    Schmieder RE; Messerli FH
    Schweiz Med Wochenschr; 1993 Jan; 123(4):99-107. PubMed ID: 7678943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The appropriate evaluation of the patient at risk for sudden death from ventricular arrhythmias.
    Green MS; Ricci J; Wolfe K
    Can J Cardiol; 2000 Jun; 16 Suppl C():13C-5C. PubMed ID: 10887271
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of electrophysiology study in risk stratification of sudden cardiac death.
    Thomas KE; Josephson ME
    Prog Cardiovasc Dis; 2008; 51(2):97-105. PubMed ID: 18774009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; DiCarlo L; Gold MR; Greer GS; Prystowsky EN; O'Toole MF; Tang A; Fisher JD; Coromilas J; Talajic M; Hafley G
    N Engl J Med; 2000 Jun; 342(26):1937-45. PubMed ID: 10874061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute myocardial ischemia and ventricular arrhythmias in the pathogenesis of sudden cardiac death in coronary disease].
    Zehender M; Faber T; Brunner M; Grom A
    Z Kardiol; 2000; 89 Suppl 3():13-23. PubMed ID: 10810781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].
    Pellnitz C; Geier C; Perrot A; Dietz R; Osterziel KJ; Haverkamp W
    Dtsch Med Wochenschr; 2005 May; 130(18):1150-4. PubMed ID: 15856398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment].
    Serdoz LV; Fabris E; Lutman C; Merlo M; Zecchin M; Sinagra G
    G Ital Cardiol (Rome); 2012 Sep; 13(9):592-601. PubMed ID: 22825344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden cardiac death, ventricular arrhythmias and hypertensive left ventricular hypertrophy.
    Dunn FG; Pringle SD
    J Hypertens; 1993 Oct; 11(10):1003-10. PubMed ID: 8258663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of Beta-Blocker in Patients with Hypertensive Left Ventricular Hypertrophy and Myocardial Ischemia.
    Koracevic G; Mićić S; Stojanovic M; Bozinovic N; Simic D; Lović D; Krstic N; Tomašević RJ
    Curr Vasc Pharmacol; 2023; 21(2):81-90. PubMed ID: 36722475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
    Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.